GlaxoSmithKline sells 100% stake in Unilever’s Indian business for $3.35 billion

On Thursday, in a statement GlaxoSmithKline said, it has agreed to sell 100% of stake in Unilever’s Indian business for nearly $3.35 billion (around 254.8 billion rupees) on the open market.

The development marks the British multinational pharmaceutical company cashing in late from the sale of the Horlicks brand.



Categories: Creativity, Entrepreneurship, HR & Organization, Strategy

Tags: , , , , , , , , , ,

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: